Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Gross Margin (2016 - 2025)

Nephros (NEPH) has 16 years of Gross Margin data on record, last reported at 61.19% in Q3 2025.

  • For Q3 2025, Gross Margin rose 10.0% year-over-year to 61.19%; the TTM value through Sep 2025 reached 63.24%, up 220.0%, while the annual FY2024 figure was 61.59%, 256.0% up from the prior year.
  • Gross Margin reached 61.19% in Q3 2025 per NEPH's latest filing, down from 63.25% in the prior quarter.
  • Across five years, Gross Margin topped out at 64.67% in Q1 2025 and bottomed at 31.63% in Q3 2022.
  • Average Gross Margin over 5 years is 56.86%, with a median of 58.65% recorded in 2023.
  • Peak YoY movement for Gross Margin: crashed -2112bps in 2022, then soared 2700bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 54.73% in 2021, then rose by 8bps to 58.99% in 2022, then rose by 5bps to 62.11% in 2023, then increased by 3bps to 63.95% in 2024, then fell by -4bps to 61.19% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 61.19% in Q3 2025, 63.25% in Q2 2025, and 64.67% in Q1 2025.